{"id":51310,"date":"2017-09-07T15:39:07","date_gmt":"2017-09-07T15:39:07","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=51310"},"modified":"2022-11-30T11:25:33","modified_gmt":"2022-11-30T16:25:33","slug":"upcoming-webinar-drug-and-alcohol-testing-of-employees-oct","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/upcoming-webinar-drug-and-alcohol-testing-of-employees-oct\/","title":{"rendered":"Upcoming Webinar: Drug and Alcohol Testing of Employees Oct. 20, 2017"},"content":{"rendered":"\n<p>Clear Law Institute provides more than 75 live webinars per month and more than 1,000 previously recorded on-demand webinars. Clear Law carefully selects presenters who are both experts and engaging speakers. For those employers currently conducting workplace drug testing or who are considering becoming a <a href=\"https:\/\/www.nationaldrugscreening.com\/employer-programs\/\"><strong>drug-free workplace<\/strong><\/a>, this webinar will help make sure you are doing it right. Industry expert,<\/p>\n\n\n\n<p>Drug and Alcohol Testing of Employees Oct. 20, 2017: Joe Reilly will be presenting this upcoming webinar and as a special offer for those who have visited the National Drug Screening Website,&nbsp;you will receive a 35% Discount by using the&nbsp;<strong>PROMO CODE&nbsp;jorei35.<\/strong><\/p>\n\n\n\n<p><a href=\"http:\/\/clearlawinstitute.com\/shop\/webinars\/drug-alcohol-testing-employees-102017\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>CLICK HERE TO REGISTER<\/strong><\/a><\/p>\n\n\n\n<p>In this webinar, you will learn about employers\u2019 options and regulatory requirements for maintaining a drug and alcohol free workplace. Upon completion of the course, you\u2019ll learn about the complex world of drug and alcohol testing, including:<\/p>\n\n\n\n<ul>\n<li>The Five Components of a Drug Free Workplace Program<\/li>\n\n\n\n<li>Drug Testing Options \u2013 Beyond the Five Panel<\/li>\n\n\n\n<li>Regulatory Issues, Including DOT Regulations<\/li>\n\n\n\n<li>Medical and Recreational Marijuana Issues<\/li>\n\n\n\n<li>Post-Accident Testing and Workers Comp Claims<\/li>\n\n\n\n<li>Effective Drug Testing while Lessening Exposure to Liability<\/li>\n<\/ul>\n\n\n\n<p>ABOUT JOE REILLY<\/p>\n\n\n\n<p>Joe Reilly serves as president of Joe Reilly &amp; Associates, Inc., as president of National Drug Screening, Inc., and as senior compliance officer for USA Mobile Drug Testing, Inc. Mr. Reilly regularly provides expert witness testimony, consulting and training programs for employers, collectors, TPA\u2019s, labs and others in the drug testing industry. Mr. Reilly is an active member of the Drug &amp; Alcohol Testing Industry Association where he was a past chairman. He is a graduate of Manhattan College.<\/p>\n\n\n\n<p><a href=\"http:\/\/clearlawinstitute.com\/shop\/webinars\/drug-alcohol-testing-employees-102017\/\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>CLICK HERE TO REGISTER<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clear Law Institute provides more than 75 live webinars per month and more than 1,000 previously recorded on-demand webinars. Clear Law carefully selects presenters who are both experts and engaging speakers. For those employers currently conducting workplace drug testing or who are considering becoming a drug-free workplace, this webinar will help make sure you are [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":53285,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51391,51535,50935,50870,50901,50862","_relevanssi_noindex_reason":"","footnotes":""},"categories":[45],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51310"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=51310"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51310\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/53285"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=51310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=51310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=51310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}